Mongolia

Mongolia

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
4.28 (3.88 - 4.70) 2019 Modelled IHME
4.44 (4.02 - 4.86) 2018 Modelled IHME
4.55 (4.08 - 5.03) 2017 Modelled IHME
4.6 (4.12 - 5.03) 2016 Modelled IHME
4.65 (4.14 - 5.15) 2015 Modelled IHME
4.75 (4.22 - 5.24) 2014 Modelled IHME
4.9 (4.34 - 5.38) 2013 Modelled IHME
5.07 (4.47 - 5.56) 2012 Modelled IHME
5.22 (4.60 - 5.75) 2011 Modelled IHME
5.34 (4.67 - 5.89) 2010 Modelled IHME
5.42 (4.75 - 5.99) 2009 Modelled IHME
5.48 (4.81 - 6.05) 2008 Modelled IHME
5.54 (4.85 - 6.11) 2007 Modelled IHME
5.59 (4.88 - 6.20) 2006 Modelled IHME
5.65 (4.88 - 6.31) 2005 Modelled IHME
5.72 (4.95 - 6.40) 2004 Modelled IHME
5.78 (4.98 - 6.49) 2003 Modelled IHME
5.85 (4.98 - 6.57) 2002 Modelled IHME
5.92 (5 - 6.69) 2001 Modelled IHME
6.01 (5.01 - 6.83) 2000 Modelled IHME
6.13 (5.11 - 6.95) 1999 Modelled IHME
6.3 (5.28 - 7.14) 1998 Modelled IHME
6.48 (5.48 - 7.32) 1997 Modelled IHME
6.63 (5.65 - 7.51) 1996 Modelled IHME
6.73 (5.70 - 7.68) 1995 Modelled IHME
6.78 (5.71 - 7.73) 1994 Modelled IHME
6.83 (5.72 - 7.81) 1993 Modelled IHME
6.87 (5.72 - 7.90) 1992 Modelled IHME
6.9 (5.71 - 7.99) 1991 Modelled IHME
6.91 (5.70 - 8.12) 1990 Modelled IHME
10.8 (8.80 - 13.31) 2015 Modelled WHO
4.1 (3.10 - 4.80) 2016 Modelled Razavi-Shearer et al, 2018
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.29 (0.20 - 0.36) 2019 Modelled IHME
0.31 (0.21 - 0.41) 2018 Modelled IHME
0.33 (0.22 - 0.43) 2017 Modelled IHME
0.32 (0.22 - 0.42) 2016 Modelled IHME
0.31 (0.21 - 0.40) 2015 Modelled IHME
0.33 (0.22 - 0.42) 2014 Modelled IHME
0.35 (0.24 - 0.46) 2013 Modelled IHME
0.4 (0.27 - 0.51) 2012 Modelled IHME
0.44 (0.29 - 0.58) 2011 Modelled IHME
0.49 (0.32 - 0.64) 2010 Modelled IHME
0.56 (0.36 - 0.73) 2009 Modelled IHME
0.64 (0.43 - 0.84) 2008 Modelled IHME
0.73 (0.49 - 0.95) 2007 Modelled IHME
0.8 (0.53 - 1.03) 2006 Modelled IHME
0.82 (0.55 - 1.07) 2005 Modelled IHME
0.82 (0.54 - 1.07) 2004 Modelled IHME
0.81 (0.52 - 1.07) 2003 Modelled IHME
0.79 (0.50 - 1.06) 2002 Modelled IHME
0.78 (0.48 - 1.06) 2001 Modelled IHME
0.78 (0.47 - 1.06) 2000 Modelled IHME
0.79 (0.49 - 1.08) 1999 Modelled IHME
0.84 (0.53 - 1.12) 1998 Modelled IHME
0.9 (0.59 - 1.19) 1997 Modelled IHME
0.99 (0.66 - 1.29) 1996 Modelled IHME
1.09 (0.75 - 1.41) 1995 Modelled IHME
1.29 (0.90 - 1.66) 1994 Modelled IHME
1.65 (1.13 - 2.14) 1993 Modelled IHME
2.12 (1.42 - 2.80) 1992 Modelled IHME
2.69 (1.78 - 3.60) 1991 Modelled IHME
3.3 (2.18 - 4.48) 1990 Modelled IHME
1.72 (1.14 - 2.57) 2015 Modelled WHO
0.5 (0.40 - 0.70) 2009 Survey/reported WHO WPRO, Woodring J et al, 2017
Showing out of
Show more
Technical notes

Number of people living with chronic HBV

National
Download
Value Year Type Source
148,908 (122,697 - 174,814) 1990 Modelled IHME
151,393 (125,232 - 175,361) 1991 Modelled IHME
153,322 (127,492 - 176,219) 1992 Modelled IHME
154,715 (129,534 - 176,726) 1993 Modelled IHME
155,680 (130,998 - 177,450) 1994 Modelled IHME
156,324 (132,363 - 178,509) 1995 Modelled IHME
155,852 (132,825 - 176,369) 1996 Modelled IHME
153,876 (130,154 - 173,816) 1997 Modelled IHME
151,235 (126,788 - 171,420) 1998 Modelled IHME
148,710 (123,797 - 168,464) 1999 Modelled IHME
147,203 (122,714 - 167,206) 2000 Modelled IHME
146,601 (123,643 - 165,447) 2001 Modelled IHME
146,322 (124,667 - 164,400) 2002 Modelled IHME
146,288 (125,961 - 164,251) 2003 Modelled IHME
146,470 (126,686 - 163,971) 2004 Modelled IHME
146,787 (126,822 - 163,832) 2005 Modelled IHME
147,363 (128,487 - 163,415) 2006 Modelled IHME
148,250 (129,792 - 163,701) 2007 Modelled IHME
149,313 (131,019 - 164,762) 2008 Modelled IHME
150,343 (131,775 - 166,211) 2009 Modelled IHME
151,141 (132,299 - 166,854) 2010 Modelled IHME
150,896 (132,927 - 166,063) 2011 Modelled IHME
149,482 (132,020 - 163,975) 2012 Modelled IHME
147,659 (130,730 - 162,300) 2013 Modelled IHME
146,270 (129,864 - 161,378) 2014 Modelled IHME
146,212 (130,031 - 161,961) 2015 Modelled IHME
147,679 (132,234 - 161,446) 2016 Modelled IHME
148,920 (133,519 - 164,690) 2017 Modelled IHME
148,043 (133,909 - 161,766) 2018 Modelled IHME
145,106 (131,459 - 159,109) 2019 Modelled IHME
126,000 (95,000 - 146,000) 2016 Modelled Razavi-Shearer et al, 2018
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
29.1 (20.30 - 39.90) 2019 Modelled IHME
29.1 (20.50 - 40) 2018 Modelled IHME
29 (20.60 - 39.80) 2017 Modelled IHME
28.6 (20.40 - 38.90) 2016 Modelled IHME
28 (20.20 - 38.10) 2015 Modelled IHME
27.9 (20.20 - 37.30) 2014 Modelled IHME
27.9 (20.60 - 36.90) 2013 Modelled IHME
28 (20.90 - 36.40) 2012 Modelled IHME
28.1 (21 - 36.20) 2011 Modelled IHME
28 (21 - 36.10) 2010 Modelled IHME
27.5 (20.60 - 35.20) 2009 Modelled IHME
26.8 (20.30 - 34.30) 2008 Modelled IHME
26.3 (19.90 - 33.40) 2007 Modelled IHME
25.8 (19.70 - 32.90) 2006 Modelled IHME
25.2 (19.20 - 32.40) 2005 Modelled IHME
24.8 (19 - 31.60) 2004 Modelled IHME
24.7 (18.90 - 31.70) 2003 Modelled IHME
24.6 (19 - 31.50) 2002 Modelled IHME
24.5 (18.90 - 31.40) 2001 Modelled IHME
24 (18.60 - 30.40) 2000 Modelled IHME
23.7 (18.40 - 29.70) 1999 Modelled IHME
23.8 (18.60 - 29.70) 1998 Modelled IHME
24 (18.90 - 30.10) 1997 Modelled IHME
24.3 (19.30 - 30.40) 1996 Modelled IHME
24.2 (19.20 - 30.40) 1995 Modelled IHME
24.1 (19 - 30) 1994 Modelled IHME
24.2 (19.10 - 30.10) 1993 Modelled IHME
24 (19 - 29.80) 1992 Modelled IHME
24 (19 - 29.90) 1991 Modelled IHME
23.9 (18.70 - 30) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
987 (689 - 1,351) 2019 Modelled IHME
970 (682 - 1,333) 2018 Modelled IHME
948 (672 - 1,301) 2017 Modelled IHME
917 (655 - 1,249) 2016 Modelled IHME
882 (636 - 1,199) 2015 Modelled IHME
859 (621 - 1,148) 2014 Modelled IHME
841 (620 - 1,113) 2013 Modelled IHME
826 (617 - 1,075) 2012 Modelled IHME
813 (607 - 1,046) 2011 Modelled IHME
794 (593 - 1,022) 2010 Modelled IHME
762 (572 - 977) 2009 Modelled IHME
729 (552 - 934) 2008 Modelled IHME
704 (534 - 895) 2007 Modelled IHME
680 (520 - 866) 2006 Modelled IHME
654 (500 - 841) 2005 Modelled IHME
635 (488 - 810) 2004 Modelled IHME
625 (479 - 802) 2003 Modelled IHME
616 (476 - 789) 2002 Modelled IHME
607 (468 - 778) 2001 Modelled IHME
587 (456 - 745) 2000 Modelled IHME
574 (445 - 721) 1999 Modelled IHME
571 (447 - 713) 1998 Modelled IHME
571 (450 - 716) 1997 Modelled IHME
572 (453 - 715) 1996 Modelled IHME
563 (445 - 707) 1995 Modelled IHME
552 (437 - 688) 1994 Modelled IHME
547 (432 - 681) 1993 Modelled IHME
536 (423 - 665) 1992 Modelled IHME
527 (418 - 656) 1991 Modelled IHME
515 (403 - 647) 1990 Modelled IHME
1,363 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
30 (22 - 39) 2019 Modelled IHME
30 (23 - 40) 2018 Modelled IHME
30 (23 - 39) 2017 Modelled IHME
30 (23 - 39) 2016 Modelled IHME
30 (23 - 39) 2015 Modelled IHME
31 (23 - 39) 2014 Modelled IHME
31 (23 - 39) 2013 Modelled IHME
31 (23 - 39) 2012 Modelled IHME
31 (24 - 39) 2011 Modelled IHME
31 (24 - 39) 2010 Modelled IHME
31 (24 - 39) 2009 Modelled IHME
31 (24 - 40) 2008 Modelled IHME
31 (24 - 40) 2007 Modelled IHME
31 (24 - 40) 2006 Modelled IHME
32 (24 - 40) 2005 Modelled IHME
32 (24 - 41) 2004 Modelled IHME
33 (25 - 42) 2003 Modelled IHME
33 (25 - 43) 2002 Modelled IHME
34 (26 - 44) 2001 Modelled IHME
35 (26 - 44) 2000 Modelled IHME
35 (27 - 45) 1999 Modelled IHME
35 (27 - 45) 1998 Modelled IHME
35 (27 - 45) 1997 Modelled IHME
35 (27 - 45) 1996 Modelled IHME
35 (27 - 45) 1995 Modelled IHME
35 (27 - 45) 1994 Modelled IHME
35 (27 - 45) 1993 Modelled IHME
35 (26 - 44) 1992 Modelled IHME
34 (26 - 44) 1991 Modelled IHME
34 (25 - 44) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of HepB birth dose

Newborns
Download
Value (%) Year Type Source
98 2018 Survey/reported WHO/UNICEF
98 2017 Survey/reported WHO/UNICEF
98 2016 Survey/reported WHO/UNICEF
97 2015 Survey/reported WHO/UNICEF
97 2014 Survey/reported WHO/UNICEF
97 2013 Survey/reported WHO/UNICEF
97 2012 Survey/reported WHO/UNICEF
96 2011 Survey/reported WHO/UNICEF
95 2010 Survey/reported WHO/UNICEF
98 2009 Survey/reported WHO/UNICEF
94 2008 Survey/reported WHO/UNICEF
97 2007 Survey/reported WHO/UNICEF
98 2006 Survey/reported WHO/UNICEF
89 2005 Survey/reported WHO/UNICEF
98 2004 Survey/reported WHO/UNICEF
99 2003 Survey/reported WHO/UNICEF
98 2002 Survey/reported WHO/UNICEF
98 2001 Survey/reported WHO/UNICEF
96 2000 Survey/reported WHO/UNICEF
98 2019 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
99 2018 Survey/reported WHO/UNICEF
99 2017 Survey/reported WHO/UNICEF
99 2016 Survey/reported WHO/UNICEF
99 2015 Survey/reported WHO/UNICEF
99 2014 Survey/reported WHO/UNICEF
98 2013 Survey/reported WHO/UNICEF
99 2012 Survey/reported WHO/UNICEF
99 2011 Survey/reported WHO/UNICEF
96 2010 Survey/reported WHO/UNICEF
97 2009 Survey/reported WHO/UNICEF
96 2008 Survey/reported WHO/UNICEF
98 2007 Survey/reported WHO/UNICEF
98 2006 Survey/reported WHO/UNICEF
98 2005 Survey/reported WHO/UNICEF
98 2004 Survey/reported WHO/UNICEF
98 2003 Survey/reported WHO/UNICEF
98 2002 Survey/reported WHO/UNICEF
95 2001 Survey/reported WHO/UNICEF
93 2000 Survey/reported WHO/UNICEF
92 1999 Survey/reported WHO/UNICEF
91 1998 Survey/reported WHO/UNICEF
88 1997 Survey/reported WHO/UNICEF
93 1996 Survey/reported WHO/UNICEF
88 1995 Survey/reported WHO/UNICEF
67 1994 Survey/reported WHO/UNICEF
69 1993 Survey/reported WHO/UNICEF
47 1992 Survey/reported WHO/UNICEF
18 1991 Survey/reported WHO/UNICEF
98 2019 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
HBV National Action Plan
HBV elimination goal
Year of HBV elimination goal
2030
HepB birth dose policy
Yes
Year of birth dose introduction
2002
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Year of HCV elimination goal
2020
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
No
NSP in at least one prison
No
OST in at least one prison
No
% of substance use disorder facilities offering hepatitis testing
Some (11-30%)
% of substance use disorder facilities offering hepatitis treatment
Some (11-30%)

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
9.34 (7.16 - 12.08) 2019 Modelled IHME
9.4 (7.25 - 12.30) 2018 Modelled IHME
9.49 (7.26 - 12.61) 2017 Modelled IHME
9.67 (7.43 - 12.78) 2016 Modelled IHME
9.88 (7.34 - 13.19) 2015 Modelled IHME
10.11 (7.57 - 13.37) 2014 Modelled IHME
10.4 (7.81 - 13.61) 2013 Modelled IHME
10.67 (8.11 - 13.80) 2012 Modelled IHME
10.88 (8.28 - 13.95) 2011 Modelled IHME
10.96 (8.33 - 14.12) 2010 Modelled IHME
10.84 (8.26 - 13.85) 2009 Modelled IHME
10.53 (8.07 - 13.33) 2008 Modelled IHME
10.15 (7.82 - 12.71) 2007 Modelled IHME
9.79 (7.55 - 12.20) 2006 Modelled IHME
9.58 (7.39 - 11.97) 2005 Modelled IHME
9.47 (7.42 - 11.73) 2004 Modelled IHME
9.37 (7.41 - 11.49) 2003 Modelled IHME
9.29 (7.34 - 11.41) 2002 Modelled IHME
9.23 (7.37 - 11.33) 2001 Modelled IHME
9.21 (7.35 - 11.34) 2000 Modelled IHME
9.2 (7.37 - 11.33) 1999 Modelled IHME
9.2 (7.40 - 11.39) 1998 Modelled IHME
9.2 (7.39 - 11.43) 1997 Modelled IHME
9.2 (7.37 - 11.47) 1996 Modelled IHME
9.2 (7.31 - 11.50) 1995 Modelled IHME
9.19 (7.33 - 11.51) 1994 Modelled IHME
9.18 (7.35 - 11.50) 1993 Modelled IHME
9.16 (7.29 - 11.45) 1992 Modelled IHME
9.15 (7.29 - 11.41) 1991 Modelled IHME
9.13 (7.26 - 11.42) 1990 Modelled IHME
6.4 (4.30 - 7.90) 2015 Modelled Blach et al, 2017
7.5 (6.10 - 10.90) 2014 Survey/reported Gower et al, 2014
Showing out of
Show more
Technical notes

Prevalence of anti-HCV

National
Download
Value (%) Year Type Source
10.8 (8.70 - 15.60) 2014 Survey/reported Gower et al, 2014
10.8 (8.70 - 15.60) 2014 Survey/reported Gower et al, 2014
Showing out of
Show more
Technical notes

Number of people living with chronic HCV (RNA+/cAg)

National
Download
Value Year Type Source
196,661 (156,414 - 245,865) 1990 Modelled IHME
200,685 (159,803 - 250,179) 1991 Modelled IHME
204,428 (162,520 - 255,461) 1992 Modelled IHME
207,814 (166,437 - 260,338) 1993 Modelled IHME
210,869 (168,275 - 264,095) 1994 Modelled IHME
213,617 (169,862 - 267,144) 1995 Modelled IHME
216,132 (173,090 - 269,592) 1996 Modelled IHME
218,484 (175,426 - 271,354) 1997 Modelled IHME
220,812 (177,491 - 273,248) 1998 Modelled IHME
223,127 (178,578 - 274,794) 1999 Modelled IHME
225,571 (180,087 - 277,675) 2000 Modelled IHME
228,496 (182,346 - 280,505) 2001 Modelled IHME
232,367 (183,587 - 285,389) 2002 Modelled IHME
237,054 (187,579 - 290,784) 2003 Modelled IHME
242,512 (189,975 - 300,447) 2004 Modelled IHME
248,611 (191,782 - 310,738) 2005 Modelled IHME
257,987 (198,837 - 321,473) 2006 Modelled IHME
271,610 (209,275 - 340,291) 2007 Modelled IHME
286,861 (219,913 - 363,083) 2008 Modelled IHME
300,823 (229,337 - 384,374) 2009 Modelled IHME
310,393 (235,739 - 399,832) 2010 Modelled IHME
314,389 (239,350 - 402,943) 2011 Modelled IHME
314,890 (239,291 - 407,295) 2012 Modelled IHME
313,349 (235,286 - 410,093) 2013 Modelled IHME
311,386 (233,147 - 411,857) 2014 Modelled IHME
310,716 (230,860 - 414,882) 2015 Modelled IHME
310,171 (238,318 - 410,167) 2016 Modelled IHME
310,523 (237,505 - 412,587) 2017 Modelled IHME
313,093 (241,351 - 409,580) 2018 Modelled IHME
316,502 (242,400 - 409,223) 2019 Modelled IHME
194,000 (131,000 - 237,000) 2015 Modelled Blach et al, 2017
Showing out of
Show more

HCV-related death rate

National
Download
Value (per 100,000) Year Type Source
30.8 (22.50 - 41) 2019 Modelled IHME
30.2 (22.20 - 39.80) 2018 Modelled IHME
29.7 (21.90 - 39.30) 2017 Modelled IHME
29.5 (21.70 - 39.20) 2016 Modelled IHME
28.8 (21.50 - 38.20) 2015 Modelled IHME
28.7 (21.80 - 37.70) 2014 Modelled IHME
28.8 (21.90 - 37.60) 2013 Modelled IHME
29 (22 - 37.60) 2012 Modelled IHME
29.4 (22.10 - 37.90) 2011 Modelled IHME
29.3 (22.20 - 37.50) 2010 Modelled IHME
28.7 (21.90 - 36.50) 2009 Modelled IHME
28 (21.30 - 35.50) 2008 Modelled IHME
27.5 (21.10 - 34.70) 2007 Modelled IHME
26.9 (20.50 - 34.30) 2006 Modelled IHME
25.9 (19.60 - 33.20) 2005 Modelled IHME
24.7 (18.80 - 31.70) 2004 Modelled IHME
23.4 (17.70 - 30.10) 2003 Modelled IHME
21.8 (16.30 - 28.30) 2002 Modelled IHME
20.4 (15.20 - 26.80) 2001 Modelled IHME
18.9 (14 - 24.70) 2000 Modelled IHME
17.9 (13.30 - 23.50) 1999 Modelled IHME
17.4 (13 - 22.70) 1998 Modelled IHME
17.1 (13 - 22.40) 1997 Modelled IHME
17.1 (13 - 22.50) 1996 Modelled IHME
16.9 (12.80 - 22) 1995 Modelled IHME
16.7 (12.80 - 21.60) 1994 Modelled IHME
16.9 (12.90 - 21.90) 1993 Modelled IHME
17.1 (13.20 - 21.90) 1992 Modelled IHME
17.3 (13.30 - 22.10) 1991 Modelled IHME
17.4 (13.10 - 22.20) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
1,044 (763 - 1,389) 2019 Modelled IHME
1,005 (740 - 1,326) 2018 Modelled IHME
973 (715 - 1,284) 2017 Modelled IHME
945 (698 - 1,258) 2016 Modelled IHME
905 (677 - 1,202) 2015 Modelled IHME
882 (670 - 1,161) 2014 Modelled IHME
870 (660 - 1,133) 2013 Modelled IHME
857 (649 - 1,110) 2012 Modelled IHME
848 (638 - 1,094) 2011 Modelled IHME
830 (627 - 1,061) 2010 Modelled IHME
796 (607 - 1,013) 2009 Modelled IHME
762 (580 - 968) 2008 Modelled IHME
735 (566 - 929) 2007 Modelled IHME
710 (540 - 903) 2006 Modelled IHME
674 (510 - 862) 2005 Modelled IHME
634 (481 - 811) 2004 Modelled IHME
593 (449 - 762) 2003 Modelled IHME
547 (407 - 708) 2002 Modelled IHME
505 (376 - 664) 2001 Modelled IHME
462 (343 - 605) 2000 Modelled IHME
433 (323 - 569) 1999 Modelled IHME
417 (313 - 546) 1998 Modelled IHME
407 (308 - 532) 1997 Modelled IHME
402 (304 - 528) 1996 Modelled IHME
392 (298 - 511) 1995 Modelled IHME
384 (293 - 496) 1994 Modelled IHME
382 (292 - 495) 1993 Modelled IHME
380 (293 - 488) 1992 Modelled IHME
379 (291 - 485) 1991 Modelled IHME
374 (283 - 477) 1990 Modelled IHME
603 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
30 (21 - 38) 2019 Modelled IHME
30 (21 - 38) 2018 Modelled IHME
30 (21 - 38) 2017 Modelled IHME
30 (22 - 38) 2016 Modelled IHME
30 (22 - 38) 2015 Modelled IHME
30 (22 - 38) 2014 Modelled IHME
30 (22 - 39) 2013 Modelled IHME
30 (22 - 39) 2012 Modelled IHME
31 (23 - 39) 2011 Modelled IHME
31 (23 - 39) 2010 Modelled IHME
31 (23 - 39) 2009 Modelled IHME
31 (23 - 40) 2008 Modelled IHME
31 (23 - 40) 2007 Modelled IHME
31 (23 - 40) 2006 Modelled IHME
31 (23 - 40) 2005 Modelled IHME
31 (23 - 40) 2004 Modelled IHME
31 (22 - 40) 2003 Modelled IHME
30 (22 - 39) 2002 Modelled IHME
30 (22 - 39) 2001 Modelled IHME
30 (21 - 38) 2000 Modelled IHME
29 (21 - 38) 1999 Modelled IHME
29 (21 - 38) 1998 Modelled IHME
29 (21 - 38) 1997 Modelled IHME
29 (21 - 38) 1996 Modelled IHME
29 (21 - 39) 1995 Modelled IHME
30 (21 - 39) 1994 Modelled IHME
30 (21 - 39) 1993 Modelled IHME
30 (22 - 40) 1992 Modelled IHME
31 (22 - 40) 1991 Modelled IHME
31 (22 - 41) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016

Number of persons treated for HCV

National
Download
Value Year Type Source
100 2015 Survey/reported WHO, 2018
6,500 2016 Survey/reported WHO, 2018
Showing out of
Show more
Technical notes
HBV National Action Plan
HBV elimination goal
Year of HBV elimination goal
2030
HepB birth dose policy
Yes
Year of birth dose introduction
2002
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Year of HCV elimination goal
2020
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
No
NSP in at least one prison
No
OST in at least one prison
No
% of substance use disorder facilities offering hepatitis testing
Some (11-30%)
% of substance use disorder facilities offering hepatitis treatment
Some (11-30%)

Overview

HBV elimination goal
Year of goal
2030
HCV elimination goal
Year of goal
2020

Hepatitis related deaths (national)

Modelled

HBV
987
2019
(689 - 1,351)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
1,044
2019
(763 - 1,389)
IHME

Survey/surveillance

No data available
HCV chart

Prevalence PWID

No data available

Birth dose vaccination coverage (national)

Survey/surveillance

HBV
98 (%)
2019
WHO/UNICEF

No. of syringes/PWID/year

Survey/surveillance

No data available
Eligible for HBV generic medicines
Eligible for HCV generic medicines

Partners